Analysis of the utilization of adjuvant drugs in our hospital during 2014 – 2016

ZHU Liang-rong; YANG Hui-hui; LIN Zhen-zhen

doi:10.3969/j.issn.1672-8157.2018.01.013

Abstract：Objective: To investigate the rules and characteristics of adjuvant drugs in our hospital, and provide references for rational use and supervise adjuvant drugs in clinic. Methods: By retrospective method, the consumption sum, frequency of drug use, defined daily cost (DDC), B/A of the top 10 adjuvant drugs in the list of consumption sum and DDDs from 2014 – 2016 were analyzed. At the same time, the prescription/medical records from hospital management information were retrospected and the relevant contents of adjuvant drugs were evaluated. Results: During 2014 – 2016, the consumption sum of adjuvant drugs increased from 20 856 100 yuan to 21 316 200 yuan. Its proportion in total consumption sum increased from 17.48% to 18.95%. The varieties of the top 10 adjuvant drugs in the list of consumption sum included drugs for activating blood circulation to dissipate blood stasis, free radical scavenger, nerve nutrition and other types drugs. The varieties of the top 10 adjuvant drugs in the list of DDDs included drugs for activating blood circulation to dissipate blood stasis, nerve nutrition, free radical scavenger, adjuvant drugs for anticancer and other types drugs. In terms of DDC, the main dosage form was injection; B/A of these drugs was poor. Free radical scavenger, drugs for activating blood circulation to dissipate blood stasis and other types drugs ranked the top 3 in respect of unreasonable use of drugs. Conclusion: The hospital should complete the management system of adjuvant drugs and improve the level of rational drug use.